Recent Developments in Patents Targeting Toll-Like Receptor Genes
Toll-like receptors (TLRs) are members of pattern recognition receptor family involved in sensing and eliciting responses against many pathogens based primarily on their molecular patterns. TLRs are major markers of innate host defence and are evolutionarily conserved across various species from insects to humans. These type I transmembrane proteins expressed by innate immune cells (dendritic cells, macrophages, NK cells), cells of the adaptive immunity (T and B lymphocytes) and non-immune cells (epithelial, endothelial cells and fibroblasts) orchestrate the adaptive immunity to combat the infections. Thirteen TLRs have been identified in mammals and the overlap between them allows recognition of a diverse range of pathogens. Recent research reviewed here is focused on modulating the innate immunity in mammals through use of TLR agonists in combating infections. Single nucleotide polymorphisms (SNPs) of TLR genes associated with incidence and course of infectious diseases and inherited diseases in human population are also reviewed.
No Supplementary Data
No Article Media
Document Type: Research Article
Publication date: 2007-11-01
More about this publication?
- Recent Patents on DNA and Gene Sequences publishes review articles by experts on recent patents on DNA and gene sequences. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in applied molecular biology.